Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PIEZO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CDK5RAP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOXP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LTB4R - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDK10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NPLOC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPS6KB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NPDC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C19orf44 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SFPQ - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZFPM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COQ4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR6791 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
YY1AP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR6859-1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMG4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on